FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

(2014) Kellie S. Rath et al.   CANCER RESEARCH

Discovery of potent anticancer agent HJC0416, an orally bioavailable small molecule inhibitor of signal transducer and activator of transcription 3 (STAT3)

(2014) Haijun Chen et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation

(2014) L. Gu et al.   MOLECULAR CANCER THERAPEUTICS

Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma

(2013) Tongsen Zheng et al.   HEPATOLOGY

Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway

(2013) Nikolas Balanis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells

(2012) Chang Xian Li et al.   PLoS One

Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia

(2011) A. Liao et al.   BLOOD

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epidemiology of Gallbladder Cancer

(2010) Guy D. Eslick   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Epidemiology of cholangiocarcinoma: An update focusing on risk factors

(2009) Hai-Rim Shin et al.   CANCER SCIENCE

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

(2009) C.-W. Chua et al.   CLINICAL CANCER RESEARCH

FTY720 Induces Apoptosis in Hepatocellular Carcinoma Cells through Activation of Protein Kinase C   Signaling

(2008) J.-H. Hung et al.   CANCER RESEARCH

Prognostic molecular markers in cholangiocarcinoma: A systematic review

(2008) Christopher D. Briggs et al.   EUROPEAN JOURNAL OF CANCER